Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients

BACKGROUND: There is increasing evidence that immunotherapy with nivolumab, an anti‐programmed death 1 monoclonal antibody, is effective in the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). However, the predictive role of hematological inflammatory ma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Matsuki, Takashi, Okamoto, Isaku, Fushimi, Chihiro, Sawabe, Michi, Kawakita, Daisuke, Sato, Hiroki, Tsukahara, Kiyoaki, Kondo, Takahito, Okada, Takuro, Tada, Yuichiro, Miura, Kouki, Omura, Go, Yamashita, Taku
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Clinical Cancer Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7367642/
https://ncbi.nlm.nih.gov/pubmed/32441463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3124
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars